You will not be allowed to compare more than 4 products at a time
View compareDescription
Zerinol Gola mint 20 mg lozenges
Ambroxol hydrochloride
What it is and what it is used for
Zerinol Gola mint contains the active ingredient ambroxol hydrochloride. The active ingredient is the component of the lozenge that provides the desired therapeutic effect.
Zerinol Gola mint has a local anesthetic effect that relieves acute sore throat pain.
Zerinol Gola mint is used for the symptomatic treatment of acute pain in sore throats in adults and children over 12 years of age.
Consult your doctor if you do not feel better or if you feel worse after 3 days.
What you need to know before taking the medicine
Do not take Zerinol Gola mint:
- if you are allergic to ambroxol hydrochloride or any of the other ingredients of this medicine (listed in section 6);
Warnings and precautions
Consult your doctor or pharmacist before taking Zerinol Gola mint.
- You should not take Zerinol Gola mint for more than 3 days. If you still have symptoms after 3 days or if you have a high fever, consult your doctor.
- If your doctor has diagnosed you with an intolerance to certain sugars, contact your doctor before taking this medicine. See also Zerinol Gola mint contains sorbitol and lactose.
- If you suffer from rare hereditary conditions of fructose intolerance.
- If you have liver or kidney problems, consult your doctor before using Zerinol Gola mint.
- Zerinol Gola mint is not suitable for the treatment of painful mouth lesions (e.g., ulcers or sores). If you have mouth ulcers, consult your doctor.
- Episodes of shortness of breath (dyspnea) may be observed due to a concomitant illness (e.g., throat swelling). Another reason may be a feeling of constriction in the throat due to the local anesthetic effect of Zerinol Gola mint. A further cause may be an allergic reaction, which can also cause swelling of the mouth and throat.
- The throat and mouth may feel less sensitive than usual (numbness).
- Cases of severe skin reactions associated with ambroxol hydrochloride administration have been reported. If you develop a skin rash (including lesions of mucous membranes such as the mouth, throat, nose, eyes, genitals), stop taking Zerinol Gola mint and contact your doctor immediately.
Children
If you are under 12 years old, you should not use Zerinol Gola mint.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking Zerinol Gola mint and inform your doctor immediately:
- allergic reaction with localized swelling of the face, lips, mouth, tongue and/or throat (angioedema). This can cause a feeling of constriction in the throat, difficulty swallowing or breathing;
- the rapid occurrence of allergic reactions affecting the whole body (anaphylactic reactions, including anaphylactic shock).
The severity of allergic reactions may increase if you take the medicine again, or if you take another medicine with the same active ingredient (see section 2 What you need to know before taking Zerinol Gola mint).
Other side effects that may occur:
Common: may affect up to 1 in 10 people
- Feeling unwell (nausea).
- Numbness of the mouth, tongue and throat (oral and pharyngeal hypoesthesia).
- Altered taste (dysgeusia).
Uncommon: may affect up to 1 in 100 people
- Diarrhea.
- Indigestion (dyspepsia).
- Stomach ache (pain in the upper abdomen).
- Dry mouth.
Rare: may affect up to 1 in 1,000 people
- Hypersensitivity reactions.
- Rash, hives.
- Dry throat.
Not known: frequency cannot be estimated from the available data
(a precise estimate cannot be made, as side effects did not occur in a clinical study group of 1226 patients. The frequency category is probably no greater than uncommon, but could be lower).
- Anaphylactic reactions, including anaphylactic shock, angioedema (rapid development of swelling of the skin, subcutaneous tissues, mucous membranes and submucous tissues) and itching.
- Severe cutaneous adverse reactions (including erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis and acute generalized exanthematous pustulosis).
- Vomiting.
If any of the side effects get worse, or if you notice any side effects not listed in this leaflet, tell your doctor, pharmacist or nurse.
Reporting of side effects
If you get any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.



